Senior insider sale
CATALYST PHARMACEUTICALS, INC. — senior position signals high conviction
$621.9K
26.75K shares
What this filing means
HARPER MOLLY plans to sell 26.75K shares of CATALYST PHARMACEUTICALS, INC. valued at approximately $621.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/12/2025ACC: 0001959173-25-007716
Director
Since Jun 2021
26.75K
Shares to sell
$621.9K
Approx. market value
26.75K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months4
Option Granted 06/29/2021
Cash
12/12/2025
20KRestricted Stock Vesting
Compensation
2/14/2025
4KRestricted Stock Vesting
Compensation
12/27/2024
1.33KRestricted Stock Vesting
Compensation
12/8/2024
1.41KTotal acquired26.75K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/12/2025 | Option Granted 06/29/2021 Cash | 20K | — |
2/14/2025 | Restricted Stock Vesting Compensation | 4K | — |
12/27/2024 | Restricted Stock Vesting Compensation | 1.33K | — |
12/8/2024 | Restricted Stock Vesting Compensation | 1.41K | — |
| Total | 26.75K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
26.75K
Market value
$621.9K
12/12/2025
Total
Units
26.75K
Value
$621.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/12/2025 | 26.75K | $621.9K | NASDAQ | Planned |
| Total | 26.75K | $621.9K | ||